We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+5.15%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$18.3B
AUM Growth
+$1.1B
Cap. Flow
-$4.59B
Cap. Flow %
-25.02%
Top 10 Hldgs %
23.58%
Holding
994
New
258
Increased
285
Reduced
146
Closed
86
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMTK
801
DELISTED
DermTech, Inc. Common Stock
DMTK
-14,494
Closed -$470K
BFX
802
DELISTED
BowFlex Inc.
BFX
-102,670
Closed -$1.86M
GOL
803
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-45,400
Closed -$446K
MRTX
804
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-13,103
Closed -$2.88M
FOCS
805
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-49,023
Closed -$2.13M
BSX.PRA
806
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
-484,157
Closed -$53M
MYOV
807
DELISTED
Myovant Sciences Ltd.
MYOV
-125,649
Closed -$3.47M
LHCG
808
DELISTED
LHC Group LLC
LHCG
-12,840
Closed -$2.74M
TPTX
809
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-19,366
Closed -$2.36M
DHR.PRA
810
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
-55,789
Closed -$84.7M
ENR.PRA
811
DELISTED
Energizer Holdings, Inc. 7.50% Series A Mandatory Convertible Preferred Stock
ENR.PRA
-262,810
Closed -$23.6M
SRE.PRB
812
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
-325,099
Closed -$33.7M
AIZP
813
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
-503,782
Closed -$65.4M
EV
814
DELISTED
Eaton Vance Corp.
EV
-80,000
Closed -$5.43M
SRE.PRA
815
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
-536,520
Closed -$53.5M
TIF
816
DELISTED
Tiffany & Co.
TIF
-100,040
Closed -$13.2M
BMY.RT
817
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-20,458
Closed -$14K
BHVN
818
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-21,361
Closed -$1.83M

Similar funds

Calamos Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Calamos Advisors held 994 positions worth $18.3B, up 6.4% from $17.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q1 2021, closing 86 positions and reducing 146 holdings. Its most notable exit was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, an estimated $84.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Calamos Advisors opened a new position in The AES Corporation worth $38.2M.

  • Calamos Advisors's largest Q1 2021 buy was The AES Corporation: 370,194 shares worth $38.2M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $462M increase.
  • Calamos Advisors's biggest Q1 2021 reduction was American Electric Power Company, Inc. Corporate Unit, cutting an estimated $32.9M.
  • Calamos Advisors fully exited Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A in Q1 2021, selling an estimated $84.7M.
  • Calamos Advisors's ten largest holdings make up 24% of its $18.3B portfolio in Q1 2021.
  • Calamos Advisors opened 258 new positions and closed 86 in Q1 2021.
  • Calamos Advisors's portfolio value rose 6.4% quarter-over-quarter to $18.3B.

Based on Calamos Advisors's 13F filing for Q1 2021, filed 12 Apr 2021.